Comparison of results with other studies on surgery for severe myopic macular hole without retinal detachment
| Sulkes et al21 (2000) | Patel et al22 (2001) | Gracia-Arumi et al11 (2001) | Current study (2002) | |
|---|---|---|---|---|
| No of myopic eyes | 13 | 20 | 24 | 10 |
| Nature of cases recruitment | Retrospective | Retrospective | Retrospective | Prospective |
| Mean follow up duration (months) | 42 | 19.9 | 25.5 | 13.3 |
| Mean age of patients (years) | 55 | 56.4 | 40 | 48.3 |
| Mean spherical equivalent (dioptres) | −10.3 | −7.48 | −10.5 | −11.8 |
| Range of spherical equivalent (dioptres) | −6.5 to −20.0 | −5.0 to −14.5 | −8.0 to −17.5 | −6.5 to −23.0 |
| Mean axial length (mm) | N/A | N/A | 28.8 | 27.7 |
| Stages of holes | ||||
| Stage 2 | 5 | N/A | N/A | 1 |
| Stage 3 | 5 | N/A | N/A | 5 |
| Stage 4 | 3 | N/A | N/A | 4 |
| Chronic macular holes of >12 months | 0 (0%) | 6 (30%) | 0 (0%) | 3 (30%) |
| Use of adjuncts | ||||
| Transforming growth factor β2 | Yes | Yes | No | No |
| Platelet growth factor | No | Yes | No | No |
| Autologous platelet concentrate | No | No | Yes | No |
| ILM removal | No | No | 10 (42%) | 10 (100%) |
| Mean preoperative VA | 20/152 | 20/100+2 | 20/200 | 20/145 |
| Mean final postoperative VA | 20/89 | 20/63 | 20/70 | 20/74 |
| No of eyes improved by two or more lines | 7 (54%) | 11 (55%) | 22 (92%) | 6 (60%) |
| No of eyes with final VA of 20/50 or better | 5 (39%) | N/A | 12 (50%) | 5 (50%) |
| No of eyes with postoperative retinal detachment | 0 (0%) | 0 (0%) | 1 (4.2%) | 2 (20%) |
| No of eyes with primary success after one operation | 10 (77%) | 12 (60%) | 21 (88%) | 9 (90%) |